French diagnostic company seeks new funding:
This article was originally published in Clinica
Diagnostic Medical Systems, a Montpellier-based diagnostic company in osteoporosis measurement, plans to raise Fr60 million ($10 million) on the French nouveau marche in May. Its densitometer in development, the Ubis 5000, gives a reading on the whole body based on readings calculated from the heel bone (calcaneus). France does not yet reimburse for osteoporosis diagnostic screening and according to Les Echos the market "is set to explode if France does decide to reimburse"
You may also be interested in...
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.